
|Articles|August 22, 2011
Are the Most Heavily Marketed Drugs the Least Beneficial?
Author(s)Jan Henderson, PhD
In a perfect world, doctors would not prescribe – and patients would not take – drugs that do more harm than good.
Advertisement
In a perfect world, doctors would not prescribe – and patients would not take – drugs that do more harm than good. But it’s complicated. The benefits and harms of drugs are determined in randomized, controlled clinical trials. For many reasons, the outcomes of such trials may not provide doctors with the information they need to decide who should take what.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Issues Complete Response Letter to Dibutepinephrine (Anaphylm) Sublingual Film for Anaphylaxis
2
Vaccine Hesitancy: Communication Strategies for Primary Care That Preserve Trust
3
GRAIL Submits FDA Premarket Approval Application for Galleri Multi-Cancer Early Detection Blood Test
4
Icotrokinra Outperforms Advanced Oral Psoriasis Treatments, Matches IL-23 Injectables in Achieving Complete Skin Clearance: Maui Derm 2026
5

































































































































